NCT04613050

Brief Summary

This study will be conducted on eighty patients of both sexes with age ranging from 35 to 45years. The will be recovered from COVID-19 infection with chest symptoms. They will be selected from Nasr city police authority hospital. They will be randomly assigned into 3 equal groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 3, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2022

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

December 28, 2022

Status Verified

December 1, 2022

Enrollment Period

2.3 years

First QC Date

October 30, 2020

Last Update Submit

December 24, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Complete blood picture

    A venous blood sample will be taken to be analyzed in the laboratory

    change from baseline at 6 weeks

  • Arterial blood gases

    arterial blood sample will be assessed

    change from baseline at 6 weeks

  • 6-minute walk Distance

    patient will be instructed to walk as fast as long as possible, in a 30 meters obstacle- free corridor, limited by turnaround cones. Standardized verbal encouragement will be given every minute. After 6 min, patient will be instructed to stop, and the total distance will be measured, rounding to the nearest meter.

    change from baseline at 6 weeks

  • Breath-hold test

    A rough index of cardiopulmonary reserve measured by the length of time that a person can voluntarily stop breathing; normal duration is 30 seconds or longer; diminished cardiac or pulmonary reserve is indicated by a duration of 20 seconds or less.

    change from baseline at 6 weeks

  • Oxygen saturation

    Percentage of haemoglobin saturated with oxygen measured by pulse oximeter

    change from baseline at 6 weeks

  • Borg Dyspnea Scale score

    It is a 0 to 10 rated numerical score used to measure dyspnea as reported by the patient during six minute walk test

    change from baseline at 6 weeks

Secondary Outcomes (1)

  • Maximum oxygen consumption

    change from baseline at 6 weeks

Study Arms (3)

Group A (Respiratory Training Group)

ACTIVE COMPARATOR

It will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive respiratory training for 6 weeks.

Other: Respiratory Training

Group B : (Aerobic Training Group)

ACTIVE COMPARATOR

It will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive aerobic training for 6 weeks

Other: Aerobic training

Group C : (control group)

NO INTERVENTION

It will include 20 patients of both sexes, recovered from COVID-19 infection on medical drugs only will receive no exercise as control group.

Interventions

Respiratory training in form of : Diaphragmatic breathing,Segmental breathing, Incentive spirometer:

Group A (Respiratory Training Group)

aerobic exercises are customized according to the patient's underlying disease and residual dysfunction. These exercises will include walking on treadmill. After an initial, 5-minute warm-up phase performed on the treadmill at a low load, each endurance training session lasted 30 minutes and ended with 5-minute recovery and relaxation phase. A total of 3-5 sessions are carried out per week. Patients who are prone to fatigue should perform intermittent exercises

Group B : (Aerobic Training Group)

Eligibility Criteria

Age35 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients recovered from COVID -19 infection.
  • Patients with body mass index 25 - 35 kg/m2
  • Patients previously diagnosed with chest symptoms of COVID- 19 infection.
  • Patients' body temperature less than 37.5
  • Blood oxygen saturation ≥95%

You may not qualify if:

  • Smokers
  • Patients with Myocardial infarction
  • Patients with diabetes.
  • Patients with autoimmune disease.
  • Patients with positive COVID -19 infection.
  • Patients with previous chest diseases
  • a heart rate of \>100 bpm
  • a blood pressure of \<90/60 mmHg or \>140/90 mmHg
  • a blood oxygen saturation of ≤95%
  • other diseases that are not suitable for exercise (osteoarthritis knee - stroke patients, etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Police hospital-Nasr city

Cairo, 002, Egypt

Location

MeSH Terms

Interventions

Breathing Exercises

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 30, 2020

First Posted

November 3, 2020

Study Start

July 2, 2020

Primary Completion

October 24, 2022

Study Completion

October 30, 2022

Last Updated

December 28, 2022

Record last verified: 2022-12

Locations